Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1995-06-29
1998-05-12
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514561, 560119, 562501, A61K 3121
Patent
active
057505667
ABSTRACT:
The present invention provides novel compounds that affect certain excitatory amino acid receptors, and are useful in the treatment of neurological disorders and psychiatric disorders.
REFERENCES:
patent: 3532744 (1970-10-01), Fletcher et al.
patent: 3704312 (1972-11-01), Russell et al.
patent: 3746495 (1973-07-01), Malis et al.
G. Costantino, et al., "Definition of a Pharmacophore for the Metabotropic Glutamate Receptors Negatively Linked to Adenylyl Cyclase", Bioorganic & Medicinal Chemistry, 1, 259-265 (1993).
J. Greenstein et al, "Chemistry of the Amino Acids", John Wiley & Sons, Inc (New York), 6, 2559-2567 (1961).
D.D. Schoepp, et al., European Journal of Pharmacology, vol. 207, 1991, pp. 351-353.
U.S. application No. 08/500,303, filed Jul. 10, 1995.
U.S. application No. 08/496,710, filed Jun. 29, 1995.
U.S. application No. 08/496,642, filed Jun. 29, 1995.
Y. Nakagawa et al., "(2S, 3S, 4S) .alpha.-(Carboxycyclopropyl) -glycine is a novel agonist of metabotropic glutamate receptors," European J. Pharmacology, 184, 205-206 (1990).
Y. Hayashi et al., "Agonist analysis of 2-(Carboxycyclopropyl) glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells," Br. J. Pharmacol., 107, 539-543 (1992).
H. Shinozaki and M. Ishida, "Recent Advances in the Study of Glutamate Receptor Agonists," Asia Pacific J. of Pharmacol., 6, 293-316 (1991).
F. Nicoletti et al., "(2s,1'.sub.R,2'.sub.R,3'.sub.R) -2-(2,3-Dicarboxycyclopropyl) glycine enhances quisqualate-stimulated inositol phospholipid hydrolysis in hippocampal slices," Eur. J. Pharmacol. -Molecular Pharmacol. Section, 245, 297-298 (1993).
M. Ishida et al., "A potent metabotropic glutamate receptor agonist: electrophysiological actions of a conformationally restricted glutamate analogue in the rat spinal cord and Xenopus oocytes," Brain Res., 537, 311-314 (1990).
M. Ishida et al., "A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord," Br. J. Pharmacol., 109, 1169-1177 (1993).
V. Bruno et al., "Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death," Eur. J. Pharmacol., 256, 109-112 (1994).
H. Kaba et al., "Induction of an Olfactory Memory by the Activation of a Metabotropic Glutamate Receptor," Science, 265, 262-264 (Jul. 8, 1994).
D.E. Jane et al., "Actions of two new antagonists showing selectively for different sub-types of metabotropic glutamate receptor in the neonatal rat spinal cord," Br. J. Pharmacol., 112, 809-816 (1994).
F. Nicoletti et al., "Effect of Metabotropic Glutamate Receptor Agonists on Excitotoxic or Apoptotic Neuronal Degeneration," Neuropschychopharmacology, 10 (3S), 623S (1994).
Monn James A.
Schoepp Darryle D.
Boone David E.
Eli Lilly and Company
Hay Martin A.
Leeds James P.
Shippen Michael L.
LandOfFree
Synthetic excitatory amino acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic excitatory amino acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic excitatory amino acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-979436